Merit Medical Systems INC Form 4 insider transactions

Neil W. Peterson, CHIEF OPERATING OFFICER of Merit Medical Systems Inc, sold 21,449 shares of common stock on August 4, 2026 for $85.00 per share.

Merit Medical Systems' Chief Human Resources Officer, Michel J. Voigt, reported a charitable gift of common stock and disposed of shares.

Brian G. Lloyd, Chief Legal Officer of Merit Medical Systems, reported a disposition of 2,000 shares of common stock via a charitable gift.

Merit Medical Systems Director Thomas J. Gunderson exercised stock options for 21,250 shares of common stock on May 20, 2026.

Director Lynne N. Ward was granted 3,457 restricted stock units under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan.

Director Scott R. Ward was granted 3,457 restricted stock units under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan.

Director Thomas J. Gunderson was granted 3,457 restricted stock units under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan.

Director Stephen C. Evans was granted 3,457 restricted stock units under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan.

Director Laura S. Kaiser was granted 3,457 restricted stock units under the Merit Medical Systems 2026 Equity Incentive Plan.

Director Silvia M. Perez was granted 3,457 restricted stock units under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan.

Director Lonny J. Carpenter was granted 3,457 restricted stock units as part of the Merit Medical Systems, Inc. 2026 Equity Incentive Plan.

Director Michael R. McDonnell was granted 3,457 restricted stock units under the Merit Medical Systems 2026 Equity Incentive Plan.

Director F. Ann Millner was granted 3,457 restricted stock units under the Merit Medical Systems 2026 Equity Incentive Plan.

Christian Adam Smith of Merit Medical Systems Inc. reported a transaction involving common stock on May 11, 2026.

Director Lynne N. Ward of Merit Medical Systems Inc. reported a sale of 5,000 shares of common stock on May 7, 2026.

Brian G. Lloyd, Chief Legal Officer and Secretary of Merit Medical Systems Inc., acquired 2,000 shares of common stock.

Raul Parra Jr., CFO and Treasurer of Merit Medical Systems Inc., reported a transaction involving the sale of common stock.

Michel J. Voigt, Chief Human Resources Officer at Merit Medical Systems Inc., acquired 2,250 shares of common stock.

Fred P. Lampropoulos has officially stepped down from his role as Executive Chairman of Merit Medical Systems, Inc.

Merit Medical Systems' Chief Legal Officer, Brian G. Lloyd, reported significant equity grants including restricted stock units and performance shares, alongside a tax-related share surrender.

Merit Medical Systems COO Neil Peterson reported recent equity transactions, including RSU and PSU grants, and tax-related share dispositions.

Merit Medical Systems Inc.'s President and CEO, Martha Goldberg Aronson, was granted 28,198 restricted stock units, vesting over three years.

Merit Medical Systems' Chief Human Resources Officer, Michel J. Voigt, reported significant equity acquisitions through RSU grants and performance share vesting, alongside tax-related share dispositions.

Merit Medical Systems' Chief Commercial Officer, Christian Adam Smith, reported significant equity transactions including RSU grants and tax-related share surrender.

Merit Medical Systems CFO Raul Parra Jr. reported significant acquisitions of restricted stock units and performance shares, alongside a tax-related share disposition.

Merit Medical Systems COO Neil W. Peterson exercised options and sold 5,000 shares of common stock for $90 per share, as part of a pre-arranged 10b5-1 trading plan.

Merit Medical Systems' Executive Chairman, Fred P. Lampropoulos, reported the sale of 10,000 shares of common stock for approximately $880,377 under a pre-arranged trading plan.

Merit Medical Systems Inc.'s Executive Chairman, Fred P. Lampropoulos, reported the sale of 25,000 shares of common stock at a weighted average price of $87.31.

Merit Medical Systems Inc.'s Executive Chairman, Fred P. Lampropoulos, sold 20,000 shares of common stock for approximately $1.7 million on November 20, 2025, under a Rule 10b5-1 plan.

Merit Medical Systems' Executive Chairman, Fred P. Lampropoulos, reported the sale of 5,000 shares of common stock at a weighted average price of $84.826 per share.